Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 11, Pages 454-457
http://dx.doi.org/10.1100/tsw.2011.61
Opinion Paper

Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry

1Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, CA, USA
2TheScientificWorld, Kirkkonummi, Finland

Received 6 February 2011; Revised 9 February 2011; Accepted 10 February 2011

Copyright © 2011 Tamas Bartfai and Graham Vaughan Lees.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • David J. Eve, Cesar V. Borlongan, and Paul R. Sanberg, “A Showcase of Bench-to-Bedside Regenerative Medicine at the 2010 ASNTR,” The Scientific World JOURNAL, vol. 11, pp. 1842–1864, 2011. View at Publisher · View at Google Scholar
  • Graham V. Lees, and Tamas Bartfaipp. 1–346, 2013. View at Publisher · View at Google Scholar
  • Fabrizio Benedetti, Elisa Carlino, and Alessandro Piedimonte, “Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects,” Lancet Neurology, vol. 15, no. 7, pp. 736–747, 2016. View at Publisher · View at Google Scholar
  • Alessandro Piedimonte, Fabrizio Benedetti, and Elisa Carlino, “Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects,” The Lancet Neurology, vol. 15, no. 7, pp. 736–747, 2016. View at Publisher · View at Google Scholar
  • Aziz Shaibani, Elisa Frisaldi, and Fabrizio Benedetti, “Placebo response in pain, fatigue, and performance: Possible implications for neuromuscular disorders,” Muscle & Nerve, 2017. View at Publisher · View at Google Scholar
  • Elisa Frisaldi, Aziz Shaibani, and Fabrizio Benedetti, “Why We should Assess Patients’ Expectations in Clinical Trials,” Pain and Therapy, 2017. View at Publisher · View at Google Scholar
  • Fabrizio Benedetti, Elisa Carlino, and Alessandro Piedimonte, “Placebos in clinical trials: unravelling a complex phenomenon – Authors' reply,” The Lancet Neurology, vol. 16, no. 1, pp. 29, 2017. View at Publisher · View at Google Scholar
  • Emily G. Severance, Faith B. Dickerson, and Robert H. Yolken, “Autoimmune phenotypes in schizophrenia reveal novel treatment targets,” Pharmacology & Therapeutics, 2018. View at Publisher · View at Google Scholar
  • Nanna B. Finnerup, Simon Haroutounian, Ralf Baron, Robert H. Dworkin, Ian Gilron, Maija Haanpaa, Troels S. Jensen, Peter R. Kamerman, Ewan McNicol, Andrew Moore, Srinivasa N. Raja, Niels T. Andersen, Emily S. Sena, Blair H. Smith, Andrew S.C. Rice, and Nadine Attal, “Neuropathic pain clinical trials,” Pain, vol. 159, no. 11, pp. 2339–2346, 2018. View at Publisher · View at Google Scholar